Fundraising FoxHealthtech Startups
18,759 companies tagged Healthtech, with their investors and founders.
Pelthos Therapeutics is a biopharmaceutical company that develops and commercializes topical treatments for infectious skin conditions and parasitic infestations. The company markets approved and pipeline therapeutic products targeting patient populations with limited treatment options.
0 investors
0 investors
Novasenta is a biotechnology company that uses single-cell analysis of human tissue samples combined with computational biology to discover novel therapeutic targets and develop treatments for immune-mediated diseases and cancer.
0 investors
0 investors
0 investors
Noveome is a clinical-stage biopharmaceutical company developing ST266, a multi-targeted secretome containing hundreds of biologically active proteins designed for neuroprotection, inflammation modulation, and tissue healing. The company is investigating ST266's potential across ophthalmology, neurology, dermatology, and other therapeutic areas.
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
0 investors
NuShores Biosciences is a medical device company developing first-to-market technologies, with a focus on bone and tissue regeneration and joint replacement applications. It operates in the biosciences and orthopaedic/regenerative medicine field.
0 investors
0 investors
Nutriband develops transdermal drug delivery systems and pharmaceutical products, with a focus on abuse-deterrent technology aimed at reducing misuse of opioid-based transdermal medications. It operates through subsidiaries covering clinical R&D, contract manufacturing, and sports recovery products.
0 investors
0 investors
0 investors
0 investors
NVMedtech develops the TUBE flow diverter, a minimally invasive implant that treats brain aneurysms by promoting rapid aneurysm occlusion and tissue growth across the aneurysm neck. The device is a medical implant for neurovascular intervention, offering high surface coverage, high pore density, and a heparin surface coating.
0 investors
0 investors
NVIGEN develops multifunctional, biodegradable magnetic nanoparticles (nanobeads) and related assays for the biomedical research and diagnostics community, supporting applications such as NGS sample preparation, DNA/RNA/protein/exosome/cell isolation, liquid-biopsy immunodiagnostics, drug delivery, and cell therapy. It also offers precision-medicine biomarker profiling and single-cell RNA sequencing products for cancer detection and personalized therapy.
0 investors